Severe kidney disease (eGFR below 30 mL/min/1.73m) represents a relative contraindication requiring specialist input
Pavone C, Napoli G, Caruana G et al: Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study
median TTAF of 2 weeks) indicates more friction than peers
Semaglutide mimics and amplifies this hormone, producing sustained appetite suppression over the course of a week from a single injection
In sum, current evidence positions GLP-1 RAs as a potential cardioprotective strategy in HF, with HF with preserved ejection fraction emerging as the clinically most relevant phenotype for the drug class, especially when occurring in people with obesity with and without diabetes
Doctronics AI doctor synthesizes the latest peer-reviewed medical expertise to provide fast answers and practical recommendations, and it remembers patients over time to tailor advice